You are currently viewing a new version of our website. To view the old version click .

Cells, Volume 11, Issue 7

April-1 2022 - 189 articles

Cover Story: Siglec-6 is an ITIM-bearing glycan-binding receptor previously identified on human mast cells; however, its properties have not been fully elucidated. Herein, Robida et al. assess the expression, endocytosis, and function of Siglec-6. This report demonstrates that Siglec-6 is highly and consistently expressed on all primary mast cells and mast cell lines examined, and that SIGLEC6 mRNA is limited to mast cells in esophageal tissue biopsies. Following the antibody ligation of Siglec-6, mast cell activation in response to stimulation through FcεRI, MRGPRX2, or C5aR is reduced, and Siglec-6 is maintained at the cell surface for prolonged periods. Coaggregating Siglec-6 with FcεRIα enhances its ability to suppress mast cell activation and reduces the activation of the phosphorylation of ERK1/2 and p38. These findings indicate that Siglec-6 is suitable as a therapeutic target on mast cells. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (189)

  • Article
  • Open Access
16 Citations
4,050 Views
19 Pages

6 April 2022

Red blood cell (RBC) deformability is modulated by the phosphorylation status of the cytoskeletal proteins that regulate the interactions of integral transmembrane complexes. Proteomic studies have revealed that receptor-related signaling molecules a...

  • Article
  • Open Access
22 Citations
6,574 Views
27 Pages

Alteration of Mitochondrial Integrity as Upstream Event in the Pathophysiology of SOD1-ALS

  • René Günther,
  • Arun Pal,
  • Chloe Williams,
  • Vitaly L. Zimyanin,
  • Maria Liehr,
  • Cläre von Neubeck,
  • Mechthild Krause,
  • Mrudula G. Parab,
  • Susanne Petri and
  • Norman Kalmbach
  • + 6 authors

6 April 2022

Little is known about the early pathogenic events by which mutant superoxide dismutase 1 (SOD1) causes amyotrophic lateral sclerosis (ALS). This lack of mechanistic understanding is a major barrier to the development and evaluation of efficient thera...

  • Review
  • Open Access
40 Citations
7,730 Views
26 Pages

6 April 2022

Cardiac hypertrophy, initiated by a variety of physiological or pathological stimuli (hemodynamic or hormonal stimulation or infarction), is a critical early adaptive compensatory response of the heart. The structural basis of the progression from co...

  • Article
  • Open Access
14 Citations
5,516 Views
13 Pages

Morphological and Immunopathological Aspects of Lingual Tissues in COVID-19

  • Dolaji Henin,
  • Gaia Pellegrini,
  • Daniela Carmagnola,
  • Giuseppe Carlo Lanza Attisano,
  • Gianluca Lopez,
  • Stefano Ferrero,
  • Antonella Amendola,
  • Danilo De Angelis,
  • Elisabetta Tanzi and
  • Claudia Dellavia

6 April 2022

COVID-19, a recently emerged disease caused by SARS-CoV-2 infection, can present with different degrees of severity and a large variety of signs and symptoms. The oral manifestations of COVID-19 often involve the tongue, with loss of taste being one...

  • Review
  • Open Access
43 Citations
5,802 Views
22 Pages

CFTR Modulator Therapies: Potential Impact on Airway Infections in Cystic Fibrosis

  • Francesca Saluzzo,
  • Luca Riberi,
  • Barbara Messore,
  • Nicola Ivan Loré,
  • Irene Esposito,
  • Elisabetta Bignamini and
  • Virginia De Rose

6 April 2022

Cystic Fibrosis (CF) is an autosomal recessive disease caused by mutations in the gene encoding for the Cystic Fibrosis Transmembrane conductance Regulator (CFTR) protein, expressed on the apical surface of epithelial cells. CFTR absence/dysfunction...

  • Article
  • Open Access
6 Citations
2,761 Views
12 Pages

Cytoplasmic Colocalization of RXRα and PPARγ as an Independent Negative Prognosticator for Breast Cancer Patients

  • Wanting Shao,
  • Melitta B. Köpke,
  • Theresa Vilsmaier,
  • Alaleh Zati Zehni,
  • Mirjana Kessler,
  • Sophie Sixou,
  • Mariella Schneider,
  • Nina Ditsch,
  • Vincent Cavaillès and
  • Udo Jeschke

6 April 2022

Retinoid X receptor α (RXRα) is a nuclear receptor (NR) which functions as the primary heterodimeric partner of other NRs including the peroxisome proliferator-activated receptor γ (PPARγ). We previously reported that, in brea...

  • Article
  • Open Access
5 Citations
4,190 Views
16 Pages

6 April 2022

Neuronal growth regulator 1 (NEGR1) is a brain-enriched membrane protein that is involved in neural cell communication and synapse formation. Accumulating evidence indicates that NEGR1 is a generic risk factor for various psychiatric diseases includi...

  • Article
  • Open Access
7 Citations
3,872 Views
21 Pages

Urine-Derived Kidney Progenitor Cells in Cystinosis

  • Koenraad Veys,
  • Sante Princiero Berlingerio,
  • Dries David,
  • Tjessa Bondue,
  • Katharina Held,
  • Ahmed Reda,
  • Martijn van den Broek,
  • Koen Theunis,
  • Mirian Janssen and
  • Elisabeth Cornelissen
  • + 6 authors

6 April 2022

Nephropathic cystinosis is an inherited lysosomal storage disorder caused by pathogenic variants in the cystinosin (CTNS) gene and is characterized by the excessive shedding of proximal tubular epithelial cells (PTECs) and podocytes into urine, devel...

  • Article
  • Open Access
27 Citations
5,156 Views
21 Pages

Plasma Metabolomic Alterations Induced by COVID-19 Vaccination Reveal Putative Biomarkers Reflecting the Immune Response

  • Ioanna Dagla,
  • Aikaterini Iliou,
  • Dimitra Benaki,
  • Evagelos Gikas,
  • Emmanuel Mikros,
  • Tina Bagratuni,
  • Efstathios Kastritis,
  • Meletios A. Dimopoulos,
  • Evangelos Terpos and
  • Anthony Tsarbopoulos

6 April 2022

Vaccination is currently the most effective strategy for the mitigation of the COVID-19 pandemic. mRNA vaccines trigger the immune system to produce neutralizing antibodies (NAbs) against SARS-CoV-2 spike proteins. However, the underlying molecular p...

of 19

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cells - ISSN 2073-4409